- Home
- Equipment
- asia middle east
- immune rejection
Refine by
Locations
- Asia & Middle East
- Afghanistan
- Armenia
- Azerbaijan
- Bahrain
- Bangladesh
- Bhutan
- Brunei Darussalam
- Cambodia
- China
- East Timor
- Georgia
- Guam
- Hong Kong
- India
- Indonesia
- Iran
- Iraq
- Israel
- Japan
- Jordan
- Kazakhstan
- Kuwait
- Kyrgyzstan
- Laos
- Lebanon
- Malaysia
- Maldives
- Mongolia
- Myanmar
- Nepal
- North Korea
- Oman
- Pakistan
- Palestinian Territories
- Philippines
- Qatar
- Russia
- Saudi Arabia
- Singapore
- South Korea
- Sri Lanka
- Syria
- Taiwan
- Tajikistan
- Thailand
- Turkmenistan
- United Arab Emirates
- Uzbekistan
- Vietnam
- Yemen
Immune Rejection Equipment Supplied In Asia Middle East
4 equipment items found
Manufactured by:HEALIOS K.K. based inTokyo, JAPAN
A universal donor cell is a kind of cell that can be used for transplantation into anyone. In other words, it is a cell in which the induction of immune rejection*１ (Human Leukocyte Antigen（HLA*２）mismatch) has been suppressed, and which can be used for patients requiring transplants ...
Manufactured by:Nano Intelligent Biomedical Engineering Corporations (NIBEC) Co., Ltd. based inJincheon-gun, SOUTH KOREA
Manufactured by removing organic components and purifying only inorganic bone mineral, OCS-H has a low rate of inflammation and immune rejection. It is a biocompatible bone graft material that is made from equine bone, of which structure is almost the same as human bone, so that it can be easily compatible with surrounding bone tissue when grafted. OCS-H bone ...
Manufactured by:R & L Medical based inHangzhou City, CHINA
R&L Medical Recombinant Type III Collagen Facial Mask is an advanced skin repair solution designed for intensive recovery and post-procedure care. Made with medical-grade recombinant humanized Type III collagen, identical to natural human collagen, it acts as a layer of “artificial skin.” The mask promotes cell regeneration, restores skin elasticity, and strengthens the skin ...
Manufactured by:HEALIOS K.K. based inTokyo, JAPAN
Induced pluripotent stem cells (iPSCs) are established by introducing several factors to somatic cells such as skin cells. iPSCs can differentiate into the cells of a various tissues or organs (pluripotency) and grow indefinitely (proliferation). The objective of iPSC regenerative medicine is to restore cellular function by replacing dysfunctional tissues with cell therapy medicines, which are ...